A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

Nils Koch-Henriksen*, Melinda Magyari, Finn Sellebjerg, Per Soelberg Sørensen

*Corresponding author for this work
32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod'. Together they form a unique fingerprint.

Medicine & Life Sciences